Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis
Clinical trial NCT04773587 · COMPLETED
Trial details
- NCT number
- NCT04773587
- Sponsor
- Arcutis Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-27
- Primary completion
- 2022-08-30
- Enrollment
- 654
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.